These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27709129)

  • 1. Cellular uptake of drug loaded spider silk particles.
    Schierling MB; Doblhofer E; Scheibel T
    Biomater Sci; 2016 Sep; 4(10):1515-1523. PubMed ID: 27709129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering of recombinant spider silk proteins allows defined uptake and release of substances.
    Doblhofer E; Scheibel T
    J Pharm Sci; 2015 Mar; 104(3):988-94. PubMed ID: 25546241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant spider silk particles as drug delivery vehicles.
    Lammel A; Schwab M; Hofer M; Winter G; Scheibel T
    Biomaterials; 2011 Mar; 32(8):2233-40. PubMed ID: 21186052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Antibacterial Activity of Se Nanoparticles Upon Coating with Recombinant Spider Silk Protein eADF4(κ16).
    Huang T; Kumari S; Herold H; Bargel H; Aigner TB; Heath DE; O'Brien-Simpson NM; O'Connor AJ; Scheibel T
    Int J Nanomedicine; 2020; 15():4275-4288. PubMed ID: 32606677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant spider silk particles for controlled delivery of protein drugs.
    Hofer M; Winter G; Myschik J
    Biomaterials; 2012 Feb; 33(5):1554-62. PubMed ID: 22079006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced cellular uptake of engineered spider silk particles.
    Elsner MB; Herold HM; Müller-Herrmann S; Bargel H; Scheibel T
    Biomater Sci; 2015 Mar; 3(3):543-51. PubMed ID: 26222296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered hybrid spider silk particles as delivery system for peptide vaccines.
    Lucke M; Mottas I; Herbst T; Hotz C; Römer L; Schierling M; Herold HM; Slotta U; Spinetti T; Scheibel T; Winter G; Bourquin C; Engert J
    Biomaterials; 2018 Jul; 172():105-115. PubMed ID: 29723755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of steam sterilization on recombinant spider silk particles.
    Lucke M; Winter G; Engert J
    Int J Pharm; 2015 Mar; 481(1-2):125-31. PubMed ID: 25596418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-Specific Functionalization of Recombinant Spider Silk Janus Fibers.
    Lang G; Grill C; Scheibel T
    Angew Chem Int Ed Engl; 2022 Mar; 61(11):e202115232. PubMed ID: 34986278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Assembly of Spider Silk-Fusion Proteins Comprising Enzymatic and Fluorescence Activity.
    Humenik M; Mohrand M; Scheibel T
    Bioconjug Chem; 2018 Apr; 29(4):898-904. PubMed ID: 29338201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designed Spider Silk-Based Drug Carrier for Redox- or pH-Triggered Drug Release.
    Herold HM; Döbl A; Wohlrab S; Humenik M; Scheibel T
    Biomacromolecules; 2020 Dec; 21(12):4904-4912. PubMed ID: 33249826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Water-based preparation of spider silk films as drug delivery matrices.
    Agostini E; Winter G; Engert J
    J Control Release; 2015 Sep; 213():134-141. PubMed ID: 26100366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant Spider Silk Bioinks for Continuous Protein Release by Encapsulated Producer Cells.
    Trossmann VT; Heltmann-Meyer S; Amouei H; Wajant H; Horch RE; Steiner D; Scheibel T
    Biomacromolecules; 2022 Oct; 23(10):4427-4437. PubMed ID: 36067476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Processing conditions for the formation of spider silk microspheres.
    Lammel A; Schwab M; Slotta U; Winter G; Scheibel T
    ChemSusChem; 2008; 1(5):413-6. PubMed ID: 18702135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomaterial building blocks based on spider silk-oligonucleotide conjugates.
    Humenik M; Scheibel T
    ACS Nano; 2014 Feb; 8(2):1342-9. PubMed ID: 24405063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant Spider Silk Hydrogels for Sustained Release of Biologicals.
    Kumari S; Bargel H; Anby MU; Lafargue D; Scheibel T
    ACS Biomater Sci Eng; 2018 May; 4(5):1750-1759. PubMed ID: 33445332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface properties of spider silk particles in solution.
    Helfricht N; Klug M; Mark A; Kuznetsov V; Blüm C; Scheibel T; Papastavrou G
    Biomater Sci; 2013 Nov; 1(11):1166-1171. PubMed ID: 32517409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic Vascularization of Recombinant eADF4(C16) Spider Silk Matrices in the Arteriovenous Loop Model.
    Steiner D; Lang G; Fischer L; Winkler S; Fey T; Greil P; Scheibel T; Horch RE; Arkudas A
    Tissue Eng Part A; 2019 Nov; 25(21-22):1504-1513. PubMed ID: 30848159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered spider silk protein-based composites for drug delivery.
    Hardy JG; Leal-Egaña A; Scheibel TR
    Macromol Biosci; 2013 Oct; 13(10):1431-7. PubMed ID: 23881554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled hydrogel formation of a recombinant spider silk protein.
    Schacht K; Scheibel T
    Biomacromolecules; 2011 Jul; 12(7):2488-95. PubMed ID: 21612299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.